Skip to main content
Have a personal or library account? Click to login
Prevalence, Awareness, Treatment, and Control of Hypertension among Adult Residents of Tehran: The Tehran Cohort Study Cover

Prevalence, Awareness, Treatment, and Control of Hypertension among Adult Residents of Tehran: The Tehran Cohort Study

Open Access
|May 2022

References

  1. Zhou B, et al. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol. 2021; 18(11): 785802. DOI: 10.1038/s41569-021-00559-8
  2. Liu J, et al. Global burden of cardiovascular diseases attributable to hypertension in young adults from 1990 to 2019. J Hypertens. 2021; 39(12): 24882496. DOI: 10.1097/HJH.0000000000002958
  3. Mills KT, et al. Global disparities of hypertension prevalence and control: A systematic analysis of population-based studies from 90 countries. Circulation. 2016; 134(6): 44150. DOI: 10.1161/CIRCULATIONAHA.115.018912
  4. Palafox B, et al. Wealth and cardiovascular health: a cross-sectional study of wealth-related inequalities in the awareness, treatment and control of hypertension in high-, middle- and low-income countries. Int J Equity Health. 2016; 15(1): 199. DOI: 10.1186/s12939-016-0478-6
  5. Cheraghian B, et al. Prevalence and associated factors of self-reported hypertension among Tehran adults in 2011: A population-based study (Urban HEART-2). Medical Journal of the Islamic Republic of Iran. 2014; 28(1).
  6. Asgari S, et al. Status of hypertension in Tehran: Potential impact of the ACC/AHA 2017 and JNC7 Guidelines, 2012–2015. Scientific Reports. 2019; 9(1). DOI: 10.1038/s41598-019-42809-3
  7. Azizi F, et al. Distribution of blood pressure and prevalence of hypertension in Tehran adult population: Tehran Lipid and Glucose Study (TLGS), 1999–2000. Journal of Human Hypertension. 2002; 16(5): 305312. DOI: 10.1038/sj.jhh.1001399
  8. Malekzadeh MM, et al. Prevalence, awareness and risk factors of hypertension in a large cohort of Iranian adult population. Journal of Hypertension. 2013; 31(7): 13641371. DOI: 10.1097/HJH.0b013e3283613053
  9. Esteghamati A, et al. Prevalence, awareness, treatment, and risk factors associated with hypertension in the Iranian population: The national survey of risk factors for noncommunicable diseases of Iran. American Journal of Hypertension. 2008; 21(6): 620626. DOI: 10.1038/ajh.2008.154
  10. Shafiee A, et al. Tehran cohort study (TeCS) on cardiovascular diseases, injury, and mental health: Design, methods, and recruitment data. Global Epidemiology. 2021; 3. DOI: 10.1016/j.gloepi.2021.100051
  11. Williams B, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39(33): 30213104. DOI: 10.1093/eurheartj/ehy339
  12. Whelton PK, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018; 71(19): e127e248. DOI: 10.1161/HYP.0000000000000076
  13. Daneshpajouh M, Barzegar MA, Nadim A. Epidemiology of cardiovascular disease in the urban population of the town of Pahlavi (North Iran). Acta Cardiologica. 1976; 31(1): 1526.
  14. Esteghamati A, et al. Awareness, treatment and control of pre-hypertension, and hypertension among adults in Iran. Archives of Iranian Medicine. 2016; 19(7): 456464.
  15. Rezaianzadeh A, et al. The prevalence and predictors of pre-hypertension and hypertension in Kherameh cohort study: a population based study on 10,663 persons in south of Iran. Journal of Human Hypertension; 2020. DOI: 10.1038/s41371-020-0330-8
  16. Gandomkar A, et al. Prevalence, awareness, treatment, control, and correlates of hypertension in the pars cohort study. Archives of Iranian Medicine. 2018; 21(8): 335343.
  17. Eghbali M, et al. Prevalence, awareness, treatment, control, and risk factors of hypertension among adults: a cross-sectional study in Iran. Epidemiology and Health. 2018; 40: e2018020. DOI: 10.4178/epih.e2018020
  18. Zhou J, et al. Changes in leisure time physical activity preferences and hypertension risk. American Journal of Health Behavior. 2019; 43(1): 145157. DOI: 10.5993/AJHB.43.1.12
  19. Rezaei S, et al. Salt intake among Iranian population: The first national report on salt intake in Iran. Journal of Hypertension. 2018; 36(12): 23802389. DOI: 10.1097/HJH.0000000000001836
  20. Arku RE, et al. Long-term exposure to outdoor and household air pollution and blood pressure in the Prospective Urban and Rural Epidemiological (PURE) study. Environ Pollut. 2020; 262: 114197. DOI: 10.1016/j.envpol.2020.114197
  21. Wang Z, et al. Status of hypertension in China: Results from the China Hypertension Survey, 2012–2015. Circulation. 2018; 137(22): 23442356. DOI: 10.1161/CIRCULATIONAHA.117.032380
  22. Di Giosia P, et al. Gender differences in epidemiology, pathophysiology, and treatment of hypertension. Current Atherosclerosis Reports. 2018; 20(3). DOI: 10.1007/s11883-018-0716-z
  23. Ford ES. Trends in mortality from all causes and cardiovascular disease among hypertensive and nonhypertensive adults in the United States. Circulation. 2011; 123(16): 173744. DOI: 10.1161/CIRCULATIONAHA.110.005645
  24. Franco OH, et al. Blood pressure in adulthood and life expectancy with cardiovascular disease in men and women: Life course analysis. Hypertension. 2005; 46(2): 2806. DOI: 10.1161/01.HYP.0000173433.67426.9b
  25. Mirzaei M, et al. Awareness, treatment, and control of hypertension and related factors in adult Iranian population. BMC Public Health. 2020; 20(1): 667. DOI: 10.1186/s12889-020-08831-1
  26. Ostchega Y, et al. Are demographic characteristics, health care access and utilization, and comorbid conditions associated with hypertension among US adults? Am J Hypertens. 2008; 21(2): 15965. DOI: 10.1038/ajh.2007.32
  27. Malekzadeh, H, et al. Trends in cardiovascular risk factors in diabetic patients in comparison to general population in Iran: findings from National Surveys 2007–2016. Sci Rep. 2020; 10(1): 11724. DOI: 10.1038/s41598-020-68640-9
  28. Kang SH, et al. Prevalence, awareness, treatment, and control of hypertension in Korea. Scientific Reports. 2019; 9(1). DOI: 10.1038/s41598-019-46965-4
  29. Kitt J, et al. New approaches in hypertension management: A review of current and developing technologies and their potential impact on hypertension care. Curr Hypertens Rep. 2019; 21(6): 44. DOI: 10.1007/s11906-019-0949-4
  30. Weisser B, et al. Single pill regimen leads to better adherence and clinical outcome in daily practice in patients suffering from hypertension and/or dyslipidemia: Results of a meta-analysis. High Blood Press Cardiovasc Prev. 2020; 27(2): 157164. DOI: 10.1007/s40292-020-00370-5
  31. Mohammadian Khonsari N, et al. Long-term trends in hypertension prevalence, awareness, treatment, and control Rate in the Middle East and North Africa: A systematic review and meta-analysis of 178 population-based studies. Curr Hypertens Rep. 2021; 23(9): 41. DOI: 10.1007/s11906-021-01159-0
  32. Khera R, et al. Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: Nationally representative cross-sectional study. Bmj. 2018; 362: k2357. DOI: 10.1136/bmj.k2357
  33. Muntner P, et al. Potential U.S. population impact of the 2017 ACC/AHA High Blood Pressure Guideline. J Am Coll Cardiol. 2018; 71(2): 109118. DOI: 10.1016/j.jacc.2017.10.073
  34. Wright JT, Jr., et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015; 373(22): 210316. DOI: 10.1056/NEJMoa1511939
  35. Xie X, et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: Updated systematic review and meta-analysis. Lancet. 2016; 387(10017): 43543. DOI: 10.1016/S0140-6736(15)00805-3
  36. Bress AP, et al. Cost-effectiveness of intensive versus standard blood-pressure control. N Engl J Med. 2017; 377(8): 745755. DOI: 10.1056/NEJMsa1616035
DOI: https://doi.org/10.5334/gh.1120 | Journal eISSN: 2211-8179
Language: English
Submitted on: Feb 7, 2022
Accepted on: Apr 25, 2022
Published on: May 11, 2022
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2022 Alireza Oraii, Akbar Shafiee, Arash Jalali, Farshid Alaeddini, Soheil Saadat, Saeed Sadeghian, Hamidreza Poorhosseini, Mohamamdali Boroumand, Abbasali Karimi, Oscar H. Franco, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.